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Graphical Abstract 
 
 
 
 
 
3-Oxo-camphorsulfonylimine was converted into alkynyl-substituted camphor derivatives. 
The 2,3-bis-alkynyl derivatives undergo a platinum-catalysed cycloisomerisation to provide 
compounds whose carbon skeleton resembles paclitaxel to some extent. 
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 Abstract 
Compounds containing two alkyne groups in close vicinity at the rigid skeleton of 
camphorsulfonamide show unique reactivities when treated with electrophiles or catalytic 
amounts of platinum(II), the product structures depending not only on the reagents but also 
on the substituents attached to the triple bonds. Cycloisomerisations with perfect atom 
economy lead to polycyclic heterocycles that resemble to some extent the AB ring system 
of paclitaxel. Herein, we present practical synthetic methods for the selective synthesis of 
precursor dialkynes bearing different substituents (alkyl, aryl) at the triple bonds, based on 
ketals or an imine as protecting groups. We show for isomeric dialkynes that the reaction 
cascade induced by Pt(II) includes ring annulation, sulfur reduction and ring enlargement. 
One isomeric dialkyne additionally allows for the isolation of a pentacyclic compound 
lacking the ring enlargement step, which we have proposed as a potential intermediate in 
the catalytic cycle.  
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 Introduction 
Enantiomerically pure raw materials, available in a sustainable manner from the natural 
“chiral pool” [1], offer a convenient entrance for the chemical synthesis of other chiral 
compounds, e.g. rare natural products and their analogues [2], or chiral catalysts [3,4]. A 
prominent example for such a “chiral pool” starting material is camphor. Both its 
substituents and its bicyclic skeleton can easily be modified and adapted to the purpose at 
hand, e.g. natural product synthesis [5]. Wagner-Meerwein and Nametkin-type rearrange-
ments are the most common reaction patterns [6], and the addition of organometallic 
reagents to the camphor carbonyl group allows for selective introduction of additional 
substituents and functional groups (e.g. as in [7]). Camphor was the source of chirality in 
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Holton’s taxol synthesis [8] and other approaches to the taxane group of compounds [9-
11]. 
From cheap camphor-10-sulfonic acid (1), a cyclic sulfonimide 2 can easily be obtained 
which is readily converted into useful auxiliaries [12], or oxidized to the oxoimide 3 
(Scheme 1) [13-15]. This versatile intermediate can be reduced to provide a chelating 
ligand for chiral catalysis [16], or oxidized to oxaziridines used as efficient chiral 
oxidizing reagents [13,17-19]. 
 
 
Scheme 1. Synthesis of 3-oxo-camphorsulfonylimine (3) [13,15] and its bis-alkynyl 
derivatives 4 from camphor-10-sulfonic acid (1). 
 
Reaction of the oxoimide 3 with two equivalents of the lithium salt of a terminal alkyne 
leads to compounds 4 where two alkynyl substituents, a sulfonamide and a hydroxy group 
are found in vicinal positions (Scheme 1) [20]. A hydroxy group neighbouring an alkynyl 
substituent, under treatment with acids, normally leads to Rupe and Meyer-Schuster 
rearrangements, forming unsaturated carbonyl compounds. This was indeed observed in 
camphor-derived bicyclic alcohols containing a single ethinyl group [21,22], occasionally 
accompanied by Wagner-Meerwein rearrangement [23], but no such products were found 
with any of the diynes 4. Our first attempts to employ 4a as a ligand with Ti(IV) resulted, 
somewhat surprisingly, in addition of HCl under simultaneous annulation (three carbon 
expansion [24,25]) of a carbocyclic five-membered ring to the 2,3-position of the bicyclic 
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camphor-derived moiety (Scheme 2a) [20]. Reactions of 4a with halogens (e.g. bromine) 
or acids were even more puzzling. In addition to the annulation, an unprecedented 
formation of a ketone accompanied by reduction of sulfur took place, to give a cyclic 
sulfinamide 6 (Scheme 2b) [26]. In this case, the mechanism of the reaction via cationic 
intermediates could be established by in situ NMR spectroscopy.  
 
 
Scheme 2. Reactions of bis-alkynyl camphor derivative 4a with TiCl4, and with Br2. 
 
Catalysis by Pt(II) can drive the reaction even further: besides annulation and sulfur 
reduction, one finds a cleavage of the C-C bond between the atoms bearing the OH and 
NH groups (ring enlargement). The result is an isomerisation of 4a and 4b to form 
tricyclic compounds 7 containing a nine-membered carbocyclic ring (Scheme 3a) [27]. 
Isomerisations are the best examples for a perfect “atom economy” [28-30] since all atoms 
of the starting material are found in the product, and thus fulfill an important requirement 
of “green chemistry” [31].  
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Scheme 3. Reactions of bis-alkynyl camphor derivatives 4 with catalytic amounts of 
PtCl2(PhCN)2. 
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A different Pt(II)-catalysed reaction cascade was observed for 4c, with adamantyl groups 
at the alkynes. Here, the annulation step is followed by a C-H bond activation process, to 
establish an additional bond to one of the adamantyl groups (8 in Scheme 3b) [32]. The 
simplest diyne 4d with R=H, in contrast, gave a ring enlargement from six to seven 
members together with a 1,2-oxygen shift instead (9 in Scheme 3c) [33]. This clearly 
demonstrates that the substituents at the triple bonds have a decisive influence on the 
outcome of the catalytic reaction. This was also confirmed by the reaction of 4e (R = 
benzyl): in addition to the expected product 7 in analogy to that of 4b, there was also a 
considerable amount of a reduced species 10 lacking sulfur reduction and ring 
enlargement, with structural similarity to the simple product from the Ti(IV) reaction with 
4a. The reducing agent is Pt(II) which is oxidised to Pt(III) during the reaction (Scheme 
3d) [34].  
Scheme 3 also depicts paclitaxel (11), an important anti-cancer drug, as there are some 
similarities (shown in red in Scheme 3) but also differences to our compounds obtained by 
Pt(II) catalysis from e.g. 4a. The eye-catching dimethylmethylene bridge over the largest 
carbocyclic ring is of course the most striking similarity, although this ring is in our 
compounds one carbon unit smaller (9 vs. 10 members in taxol) and lacks the oxygen 
substituent bearing the amino acid side group. In both compounds, we find a keto group in 
the largest ring. Instead of the six-membered ring annulation in taxol, there are the 
substituents of the original triple bonds in our compounds, precisely in the same positions. 
And where taxol has the bridgehead hydroxy and its neighbouring benzoate groups, we 
find the heterocyclic reduced isothiazole ring in the product of the Pt(II) catalysis. Other 
camphor derivatives prepared as entrance to taxoid compounds have a carbocyclic ring at 
this place in the precursor [10] and a nine-membered ring with a keto group after oxidative 
bond cleavage [11]. The similarities between our materials and taxol do, of course, not 
mean that similar biological activity is necessarily involved, but it might be worthwhile 
investigating. 
Since the results of the Pt(II) catalysis depend on the nature of the substituents at the 
alkyne groups, it would be of interest to explore the course of the reaction when the two 
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substituents are different. In this article, we develop reasonable synthetic procedures for 
the starting diynes, and present the first result of a catalytic Pt(II) reaction of such mixed 
substituted compounds. 
 
 Results and Discussion 
For the preparation of the diynes 4, a 2:1 ratio (or slightly larger for complete reaction) of 
the lithium salt of a terminal alkyne and of the oxoimide 3 is applied. The ratio should, 
however, not be increased too much. For instance, with benzylacetylene, the expected 
diyne 4e (Scheme 3d) is obtained, with only traces of monosubstituted compounds. 
However, with a 3:1 ratio, the main product is formed by reaction of only one equivalent 
of lithium salt with the C=N double bond, leaving the carbonyl group intact. In addition, 
the new propargyl group is isomerized to an allene moiety, obviously by the excess of the 
strongly basic lithium salt [35]. This unexpected monosubstitution remains unexplained 
and cannot be used as basis for a general selective synthesis of monoalkynyl camphor 
derivatives. Alkynes can also be cleaved from the bis-alkynyl compounds 4 by reaction 
with CuCl, but again, there are selectivity issues that prevent a general application [36]. 
We therefore set out to explore whether some selectivity is observed when lithium salts of 
terminal alkynes are reacted with the oxoimide 3 in a 1:1 ratio (Table 1). As alkyne 
precursors, phenylacetylene, 1-heptyne, 1-ethynyladamantane and 1-ethynyl-1-
methoxycyclohexane were used. In all cases, mixtures of 12 and 13, together with starting 
oxoimide 3 and the bis-alkynyl product 4 were obtained. Very slow addition of the 
acetylide and dilute oxoimide solutions slightly improved the yields of the mono-adducts 
12 and 13, but the formation of the bis-adducts could not be fully suppressed. With 
increasing bulk of the alkyne substituent (R = adamantyl, methoxycyclohexyl) the reaction 
tends to become more selective towards mono-addition, but less selective with respect to 
the alkylation site, and the 2-alkynyl and 3-alkynyl products are formed in similar 
amounts. Alkynes with small substituents (e.g. heptyne or phenylacetylene) preferentially 
attack at the C=N bond of the sulfonylimine, suggesting that the carbon atom of the C=N 
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is more electrophilic than that of the C=O bond. With bulkier alkynes (e.g. 1-
adamantylacetylene or 1-methoxy-1-ethynyl-cyclohexane), attack at the carbonyl group 
becomes more pronounced. Presumably, the C=O carbon atom in 3-oxo-
camphorsulfonylimine is sterically more accessible, whereas the sulfonylimine C=N 
carbon is more electrophilic. Steric and electronic properties thus counteract and the 
overall selectivity of the reaction depends on a balance between both factors.  
 
 
 
Entry R 12 : 13 Yield 12+13 
a Phenyl 80:20 42 % 
b n-pentyl 90:10 35 % 
c 1-adamantyl 70:30 88 % 
d 1-methoxycyclohexyl 50:50 67 % 
 
Table 1. Selectivity in the reaction of oxoimide 3 with alkynyl lithium compounds.  
  
Whilst chromatographic separation of the mixture of the monoadducts 12 + 13 from the 
starting material 3 and the bis-adduct 4 is straightforward, the isolation of pure 12 and 13 
requires careful control of the chromatography conditions (SiO2, CHCl3/diethyl ether 
gradient 0 to 10 %), and has been used on a small scale for analytical purposes only. The 
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ratios 12 : 13 given in Table 1 were determined by integration of the signals of the methyl 
groups in the 1H NMR, and ratios in the crude product and after isolation of the mixture of 
12 and 13 by chromatography were found consistent. 
In the IR spectra, compounds 12 show a typical NH stretching vibration at approximately 
3217 cm-1, and a C=O stretch at 1764 cm-1. Compounds 13, in contrast, can be recognised 
by their OH stretching vibration at 3444 cm-1 and the C=N stretch at 1653 cm-1. Both 
compounds display a C≡C stretch at very similar wavenumbers around 2227 cm-1, and 
asymmetric and symmetric SO2 stretching vibrations. These are found at about 1314 and 
1143 cm-1 in compounds 12, and at slightly higher wavenumbers of approx. 1330 and 1160 
cm-1 in 13. In the 1H NMR spectra, the signals of the geminal methyl groups come with a 
chemical shift difference of about 0.2 ppm in 12, but almost coincide to form one signal in 
compounds 13. The opposite holds true for the diastereotopic protons of the CH2SO2 
moiety, which nearly coincide in 12, but come as two doublets spaced about 0.2 ppm apart 
in 13. Compounds 12 display a singlet near 5 ppm for the SO2NH proton, whereas 13 show 
a singlet for the OH group at about 3.2 ppm. Similarly, the 13C NMR signals of the methyl 
groups nearly coincide in 13 but are approximately 2 ppm apart in 12. Compounds 12 
show a signal for the C=O near 206 ppm and one for the sulfonamide carbon at about 65 
ppm. In compounds 13, there is a signal for the C=N around 194 ppm and one for the 
tertiary alcohol carbon near 73 ppm. All other signals of the camphor framework and the 
alkynyl substituent come at relatively similar values and do not allow to distinguish 
between 12 and 13 reliably. 
 
In view of the above results, it was clear that a more selective method was needed that 
generally allows for mono-alkynylation and for differentiation between the carbonyl group 
and the sulfonylimine. One way to achieve this could be in the chemoselective reduction of 
either the C=N group of oxoimide 3, addition of the alkynyl moiety to the carbonyl group, 
and re-oxidation of the sultam to the sulfonimide (see Scheme 4). A number of reductions 
of oxoimide 3 have been described in the literature, using a variety of reducing agents. All 
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of them lead either to complete reduction or unselective reduction of the C=N and C=O 
bond. Thus, LiAlH4 reduces the C=O and C=N group of 3, and 3-exo-hydroxy-
camphorsultam is obtained in good yields [16]. Under Meerwein-Ponndorf-Verley 
conditions (Al(OiPr)3/iPrOH) a mixture of the 3-hydroxy-imine, 3-oxo-camphorsultam and 
3-exo-hydroxy-camphorsultam is produced. Prolonged reaction over several weeks 
eventually leads to 3-exo-hydroxy-camphorsultam as the sole product.  
 
 
Scheme 4. Attempted selective synthesis of 3-alkynyl derivatives via sulfonylimine 
reduction of oxoimide 3. 
 
We now found that the sulfonylimine of 3 can be reduced selectively to the sultam 14 in 
the presence of Zn/HOAc, as shown in Scheme 4. The product shows an IR stretching 
vibration at 1760 cm-1 and a 13C NMR signal at 209.7 ppm for the unreacted C=O group. 
The presence of the sultam can be deduced from the NH stretching vibration at 3180 cm-1, 
a 13C signal of the sulfonamide carbon at 65.0 ppm and a 1H NMR signal for the NH at 
5.57 ppm. These data are very similar to those of compound 12 where C=O and 
sulfonamide coexist. In contrast to 12, the 1H NMR signal of the NH in 14 comes as a 
doublet, due to coupling with the adjacent CH proton at 3.58 ppm, which is also split into a 
doublet. Introduction of an alkynyl substituent into the 3-position does not pose any 
problem and can be achieved by reaction with PhC≡CLi under standard conditions, to 
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produce 15 in high yields. Two equivalents of the acetylide are needed because the first 
one deprotonates the nitrogen of the sultam before the second equivalent undergoes the 
desired nucleophilic addition to the carbonyl group. Attempts to re-oxidise the sultam 15 to 
the sulfonimide 13, using Cl2/pyridine [37] or N-tert-butylphenylsulfinimidoyl 
chloride/DBU [38] under literature conditions, were unsuccessful due to the sensitivity of 
the alkyne to oxidising conditions.  
Our next strategy was to modify the carbonyl group in the 3-position and introduce the 
alkyne at the sulfonamide side, as shown in Schemes 5 and 6. The carbonyl group in 3 can 
be protected selectively as an acetal by reaction with orthoformates at room temperature in 
the presence of an acid. Thus, 3,3-dimethoxy-camphersulfonylimine (16) and 3,3-
diethoxy-camphersulfonylimine (16’) were prepared [18,39]. Subsequent reaction of these 
acetals with one equivalent of lithium phenylacetylide or 1-heptynyl lithium under 
conditions described above for the synthesis of 12 and 13 introduced the alkyne into the 2-
position of the camphor skeleton, to provide the sultams 17. Removal of the acetal 
protecting group occurred under comparatively mild conditions by stirring a mixture of 17 
with acetone and conc. HCl. Acetone as solvent was best as it allows for trans-acetalisation 
to acetone dimethylacetal and 12 rather than hydrolysis to methanol and 12. Overall, yields 
are higher throughout when the methyl acetal is used. To obtain the camphor-derived 
hydroxysultam 18 bearing an alkyne substituent in 2-position rather than in 3-position, 12 
was reduced with NaBH4 under standard conditions. Compound 18 was made for 
comparison of the analytical data with that of compound 15. Although the IR spectra look 
fairly similar, the two isomers can be distinguished from their NMR spectra, in particular 
1H and 13C signals of the atoms in 2 and 3 position. Thus, the proton in the 3-position in 18 
comes at higher chemical shift than the one in the 2-position in 15 (4.31 ppm vs. 3.67 
ppm). Likewise, the signals of carbons 2 and 3 are further downfield, when a hydrogen is 
attached to them. Also carbon 4 is affected and appears at higher chemical shift in 15 
where the alkynyl substituent is nearby. 
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Scheme 5. Selective synthesis of 2-alkynyl derivatives by protection of the 3-oxo group as 
an acetal. 
 
 
Scheme 6. Selective synthesis of 2-alkynyl derivatives by protection of the 3-oxo group as 
an imine. 
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As an alternative to the introduction of an acetal, an imine was tested for its suitability as a 
protecting group for the carbonyl moiety, as shown in Scheme 6. 3-Oxo-
camphorsulfonylimine (3) was converted into the imine 19 by reaction with 2-
phenylethylamine in the presence of TiCl4 [40]. Reaction of 19 with one equivalent of the 
lithium phenylacetylide under the conditions described above for the synthesis of 12 and 
13 provided the sultam 20 selectively, with exclusive introduction of the alkyne into the 2-
position at the camphor skeleton [41]. When two equivalents of the acetylide are used, the 
reaction still produces 20 only, and no reaction at the 3-position in the imine was 
observed. The high selectivity of this reaction can be explained by the large difference 
between the electron deficient sulfonylimine and the electron rich imine. The 
sulfonylimine carbon atom is significantly more electrophilic and thus more prone to 
attack by the acetylide. In the case of 3-oxo-camphorsulfonylimine, this difference 
between the reactive functional groups (C=O vs. C=N-SO2R) was much less pronounced, 
leading to poor selectivity. The general 1H and 13C signal pattern of the camphor skeleton 
in compound 20 is fairly similar to the one found for compounds 12, indicating that the 
alkyne has indeed been introduced at the sulfonamide side. Also the 13C signal at 175.8 
ppm shows clearly the presence of the imino group in 3-position. For a sulfonimide, a 
signal at higher ppm values (approx. 190 ppm) would have been expected. The removal of 
the imine protecting group turned out to be somewhat difficult and could only be 
performed under relatively harsh acidic conditions with aqueous HCl under reflux to 
provide 12 in moderate yield. Overall, protection of the carbonyl group as an acetal 
appears more convenient than as an imine. 
Starting from the 2-alkynyl-3-oxo compound 12a, the mixed bis-alkynyl compound 21a 
was prepared by reaction with 1-heptynyl lithium, and accordingly, 21b was obtained from 
reaction of 12b with PhC≡CLi (Scheme 7) [41,42]. Two equivalents of the alkynyl lithium 
compound are necessary because the first one is used for deprotonation of the relatively 
acidic proton at the sulfonamide nitrogen.  
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Scheme 7. Synthesis of the bis-alkynyl derivatives bearing different alkyne substituents 
and their platinum catalysed cycloisomerisation. Compounds 21a and 22a: R1 = Ph, R2 = 
pentyl; compounds 21b, 22b and 23: R1 = pentyl, R2 = Ph. 
 
Compounds 21a and 21b were then reacted with 5 mol % PtCl2(PhCN)2 at 60 oC in CHCl3 
[42]. For 1H NMR monitoring, the same conditions were applied, but CDCl3 was used as 
solvent. Within 10 hours, compound 21a converts cleanly into product 22a, and no 
intermediates or side products were detected. Under microwave irradiation, the reaction 
can be completed within 30 min at 80 oC, without impairing the selectivity. The structure 
of 22a is analogous to the one observed previously with the bis-phenylalkynyl compound 
[27] as a starting material. Cyclisation of the alkynes and a three carbon ring enlargement 
lead in a single step to a rare bicyclic carbon framework that bears some similarity to that 
of the anti-cancer drug paclitaxel. Remarkably, the sulfonamide group was reduced to a 
sulfinamide in the course of the reaction, and one of the former alkynyl carbons was 
oxidised to a ketone. The presence of the sulfinamide can be deduced from the 
fragmentation pattern in the mass spectrum where the loss of SO can be seen, and also 
from the IR spectrum. Only one S=O vibration can be identified at 1098 cm-1, in a similar 
position as the S=O vibrations in DMSO (1050 cm-1) or t-butylsulfinamide (1032 cm-1) 
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[43]. The strong band at about 1330 cm-1, typical for the asymmetric S=O stretch in 
sulfonamides and sulfones, is absent in 22a. The IR spectrum also shows the presence of 
two carbonyl groups at 1680 and 1611 cm-1, and these are confirmed in the 13C NMR 
spectrum (signals at 198.3 and 210.8 ppm). The NH of the sulfinamide seem to be strongly 
involved in hydrogen bonding with the carbonyl group nearby, as evidenced from the NH 
stretching vibration in the IR at 3110 cm-1 and the 1H NMR signal at an unusually high 
chemical shift of 11.97 ppm. The ring expanded carbon skeleton has been corroborated 
from 1H/13C NMR together with 2D experiments, which allowed for a complete and 
unequivocal assignment of all signals. 
Upon reaction with catalytic amounts of PtCl2(PhCN)2, compound 21b converts into two 
products, apparently in a parallel reaction, and these were separated by chromatography. 
One product is the expected 22b, whose structure is analogous to 22a described above. The 
other one, 23, has undergone alkyne cyclisation but the ring expansion has not yet taken 
place. The sulfonamide reduction and formation of the ketone are just about to occur, as 
the oxygen atom involved is on its way of being transferred from the sulfur onto the carbon 
atom. The structure of 23 was established by two-dimensional 1H/13C NMR experiments, 
and by comparison with relatively similar compounds obtained in the reaction of the 
bis(phenylalkynyl)-derivative of 4a with triflic acid [26], or with K[ReO4] [27]. The 
polycyclic carbon skeleton in these is identical, but the latter compounds are protonated at 
the sulfonimide nitrogen and form the triflate or perrhenate salts. The newly formed five-
membered ring in 23 is evident from the 13C NMR signals at 84.0, 90.0, 138.5, 136.0 and 
125.5 ppm, and a 1H signal at 5.80 ppm. The enolate carbon is detected at 151.4 ppm in 
13C NMR. Neither NMR nor IR shows any evidence for carbonyl groups, but there is a 
medium intense C=C stretching vibration at 1653 cm-1 and two strong bands at 1324 cm-1 
and 1059 cm-1 for the asymmetric and symmetric stretches of the O=S=N moiety. 
Compared to the SO2 moiety in sulfonamides (e.g. 21b with 1330 cm-1 and 1128 cm-1) the 
symmetric stretch is at unusually low wavenumbers.  
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The formation of products 22 and 23 can be explained from the proposed reaction 
mechanism, shown in Scheme 8. Attack of the catalyst at the OH and possibly at the 
alkyne in the immediate neighbourhood could be inferred from the fact that the 1H signal 
of the OH of 21 broadens significantly upon addition of PtCl2(PhCN)2. Concomitantly, a 
small amount of uncoordinated PhCN is observed in the 1H NMR spectrum. The 
coordinated Pt center, as a Lewis acid, promotes the release of the OH proton from A and 
its transfer onto one of the alkyne carbons to form intermediate B. The resulting vinylic 
carbocation undergoes an electrophilic attack at the neighbouring alkyne, which in turn 
reacts with the sulfonamide oxygen nearby. Both steps are strongly facilitated by the 
geometry changes when the linear alkyne moieties convert into bent alkene ones, as the 
reactive center is literally pushed into the functional group it next reacts with. Intermediate 
D can be seen as the common precursor for the parallel formation of the observed products, 
23 by dissociation from the Pt catalyst and proton migration from the sulfonamide to the 
alcoholate, and 22 by a cascade of electron movements as indicated by the arrows in D. 
 
 
 
Scheme 8. Proposed mechanism of the platinum catalysed cycloisomerisation.  
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 Conclusion 
Several methods for the synthesis of camphor-derived dialkynes having two different 
alkynyl substituents in close vicinity to each other and to a sulfonamide group were 
developed. Ketals turned out to be most efficient for the protection of carbonyl groups, 
leading to pure dialkynes with a well defined substitution pattern. The reactivity of a pair 
of isomers containing a phenyl and a pentyl group attached to the triple bonds towards 
cycloisomerisation induced by Pt(II) catalysis was studied. The expected annulation – 
sulfur reduction – ring enlargement cascade leading to a product resembling paclitaxel to 
some extent was found in both cases. However, one of the isomers yielded a second 
product lacking the ring enlargement step and containing an additional sulfur – oxygen – 
carbon linkage. The platinum complex of this compound was postulated before as an 
intermediate in the sulfur reduction step of the cascade reaction, and the isolated product 
thus supports our mechanistic considerations. Platinum(II) catalysis applied to camphor-
derived dialkynes with two different substituents can thus not only give valuable insight in 
the mechanism of such cycloisomerisations and help to clarify the role of the substituents, 
but also yield a novel type of taxoid compounds of complex polycyclic structures with 
potential biological effects.  
 
 Supporting Information File 1:  Experimental Section containing a description 
of the materials and instrumentation, and the preparation of the new compounds, as well as 
the 1H and 13C NMR spectra of compounds 12a, 12b, 13a, 17a, 17b, 18, 19, 20, 21a, 21b, 
22a, 22b and 23. 
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 Experimental Section  
 Materials and Instrumentation. 3-Oxo-camphorsulfonylimine (3) [13,15] and 
the 3,3-dialkoxy-camphorsulfonylimines 16 and 16’ [18] were prepared according to the 
literature. Reactions involving carbanions or TiCl4 were carried out in an N2-atmosphere. 
Syntheses under microwave irradiation were performed in an Anton Paar Monowave 400 
reactor in sealed vials. C, H, N and S elemental analyses were carried out on VarioEL III 
CHNS and Leeman CE-440 CHN elemental analyser. Melting points were determined with 
a Büchi 530 apparatus in open capillaries. For TLC, Merck UV 254 SiO2-plates have been 
used. Mass spectra were obtained on a Thermoquest MAT 95XL instrument. Infrared 
spectra (4000-400 cm-1) were recorded on Perkin Elmer 2000 FTIR and Nicolet Avatar 
320 FT-IR instruments in KBr pellets. 1H and 13C one- and two-dimensional NMR 
experiments were performed on Varian UNITY 300, Varian MERCURYplus 400, Bruker 
AM 360, Bruker AV 500 and Bruker DRX 500 spectrometers at ambient temperature. 
Signals were assigned with the help of COSY, NOESY, HMQC, HSQC and HMBC 
spectra. 
Preparation of the Mono-alkyne derivatives 12 and 13 from 3-oxo-camphorsulfonyl-
imine (3). 
Similar as described in [33], a solution of the alkyne (2.1 mmol) in dry diethyl ether (5 ml) 
was cooled in an ice bath. Butyl lithium (1.6M in hexanes, 1.25 ml, 2 mmol) was added 
and the reaction mixture was left at room temperature for 30 min, before it was added 
dropwise to a suspension of 3-oxo-camphorsulfonylimine (3) (460 mg, 2 mmol) in dry 
diethyl ether (5 ml). The reaction mixture was stirred overnight, water (5 ml) was added 
and the organic phase was separated. The aqueous phase was extracted twice with 
dichloromethane, and the combined organic phases were dried with Na2SO4. After 
chromatography on SiO2 (eluent CH2Cl2/Et2O 9:1) the mixture of the 2- and 3-substituted 
compounds 12 and 13 was obtained as a colourless oil (12 and 13 elute together). From 
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this mixture, the ratio 12:13 was determined by 1H NMR spectroscopy. Compounds 12 and 
13 could be separated by chromatography on SiO2, using a CHCl3/diethylether gradient 0 
to 10 % as eluent. 
a) Reaction with phenylacetylene:  
Yield is 42 %, 12a:13a = 80:20. Anal. Calcd for C18H19NO3S: C, 65.65; H, 5.81; N, 4.25; 
S, 9.71.  Found: C, 65.40; H, 5.80; N, 4.51; S, 9.68. CI-MS, m/z: (M is 329.421) 330 [M + 
H]+.  
(3aS,7aS)-8,8-Dimethyl-7-oxo-7a-phenylethynyl-1,4,5,6,7,7a-hexahydro-3H-3a,6-
methano-2,1-benzisothiazole 2,2-dioxide (12a).  
Colourless solid. M.p. 147-148 oC. TLC on SiO2, Rf = 0.40 (eluent CHCl3/Et2O 9:1). IR 
spectrum (selected bands), cm-1: 3218 s ν(NH), 2226 w ν (C≡C), 1760 s ν (C=O), 1312 
and 1143 s ν (SO2). 1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 1.08 (s, 3H) and 
1.26 (s, 3H)(H-9 and H-10), 1.89 (m, 1H), 2.08 (m, 2H) and 2.48 (m, 1H)(H-5 and H-6), 
2.48 (m, 1H, H-4), 3.42 (d, J = 13.0 Hz, 1H) and 3.46 (d, J = 13.0 Hz, 1H)(H-8), 5.44 (s, 
1H, NH), 7.30 (m, 3H) and 7.45 (m, 2H)(Ph). 13C NMR spectrum (125 MHz) in CDCl3, δ 
(ppm): 19.9 and 22.8 (C-9 and C-10), 21.9 (C-5), 29.2 (C-6), 45.4 (C-7), 49.9 (C-8), 57.4 
(C-1), 58.6 (C-4), 65.5 (C-2), 84.3 and 90.0 (C≡C), 121.6, 128.5, 129.4 and 132.2 (Ph), 
205.7 (C-3). 
(3aS,7R)-7-Hydroxy-8,8-dimethyl-7-phenylethynyl-4,5,6,7-tetrahydro-3H-3a,6-
methano-2,1-benzisothiazole 2,2-dioxide (13a).  
Colourless solid. M.p. 160-162 oC. TLC on SiO2, Rf = 0.38 (eluent CH2Cl2/Et2O 9:1). IR 
spectrum (selected bands), cm-1: 3442 s ν(OH), 2223 w ν (C≡C), 1652 s ν (C=N), 1334 
and 1166 s ν (SO2). 1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 1.15 (s, 3H) and 
1.16 (s, 3H)(H-9 and H-10), 1.90 (m, 1H), 2.09 (m, 2H) and 2.32 (m, 1H)(H-5 and H-6), 
2.44 (d, J = 4.6 Hz, 1H, H-4), 3.20 (d, J = 13.2 Hz, 1H) and 3.33 (d, J = 13.2 Hz, 1H)(H-8), 
3.41 (s, 1H, OH), 7.37 (m, 3H) and 7.50 (m, 2H)(Ph). 13C NMR spectrum (125 MHz) in 
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CDCl3, δ (ppm): 21.0 and 21.1 (C-9 and C-10), 23.9 (C-5), 27.8 (C-6), 47.5 (C-7), 50.1 (C-
8), 56.0 (C-4), 64.2 (C-1), 73.4 (C-3), 85.5 and 89.0 (C≡C), 121.2, 128.4, 129.3 and 131.9 
(Ph), 194.0 (C-2). 
b) Reaction with 1-heptyne: 
Yield is 35 %, 12b:13b = 90:10. Anal. Calcd for C17H25NO3S: C, 63.13; H, 7.79; N, 4.33, 
S, 9.91.  Found: C, 62.99; H, 7.99; N, 4.14; S, 9.76. CI-MS, m/z: (M is 323.458) 324 [M + 
H]+, 260 [M - SO2]+.  
 (3aS,7aS)-7a-Heptynyl-8,8-dimethyl-7-oxo-1,4,5,6,7,7a-hexahydro-3H-3a,6-methano-
2,1-benzisothiazole 2,2-dioxide (12b).  
Colourless solid. TLC on SiO2, Rf = 0.42 (eluent CH2Cl2/Et2O 9:1). IR spectrum (selected 
bands), cm-1: 3217 s ν(NH), 2227 w ν (C≡C), 1764 s ν (C=O), 1314 and 1142 s ν (SO2). 
1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 0.81 (t, 7.1 Hz, 3H, heptynyl-7), 1.02 (s, 
3H, H-10), 1.21 (s, 3H, H-9), 1.29 (m, 4H, heptynyl-6 and -5), 1.45 (quint., J = 7.2 Hz, 2H, 
heptynyl-4), 1.75 (m, 1H, H-5 endo), 1.99 (m, 2H, H-6 and H-5 exo), 2.18 (t, J = 7.2 Hz, 
2H, heptynyl-3), 2.39 (m, 1H, H-6), 2.38 (m, 1H, H-4), 3.32 (“s”, 2H, H-8), 5.15 (s, br., 
1H, NH). 13C NMR spectrum (125 MHz) in CDCl3, δ (ppm): 14.2 (CH3 heptynyl-7), 19.1 
(CH2 heptynyl-3), 20.0 (C-10), 21.9 (C-5), 22.3 (CH2 heptynyl-6), 22.8 (C-9), 28.1 (CH2 
heptynyl-4), 29.2 (C-6), 31.2 (CH2 heptynyl-5), 45.2 (C-7), 49.9 (C-8), 57.0 (C-1), 58.7 (C-
4), 65.6 (C-2), 75.7 and 91.7 (C≡C), 206.3 (C-3). 
(3aS,7R)-7-Heptynyl-7-hydroxy-8,8-dimethyl-4,5,6,7-tetrahydro-3H-3a,6-methano-
2,1-benzisothiazole 2,2-dioxide (13b).  
Colourless solid. TLC on SiO2, Rf = 0.40 (eluent CH2Cl2/Et2O 9:1). IR spectrum (selected 
bands), cm-1: 3452 s ν(OH), 2227 w ν (C≡C), 1653 s ν (C=N), 1328 and 1155 s ν (SO2). 
1H NMR spectrum (400 MHz) in CDCl3, δ (ppm): 0.82 (t, J = 7.2 Hz, 3H, heptynyl-7), 
1.00 (s, 3H, H-10), 1.02 (s, 3H, H-9), 1.30 (m, 4H, heptynyl-6 and -5), 1.46 (m, 2H, 
heptynyl-4), 1.68 (m, 1H, H-5), 1.91 (m, 1H, H-6), 1.93 (m, 1H, H-5), 2.20 (t, J = 7.4 Hz, 
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2H, heptynyl-3), 2.04 (m, 1H, H-6), 2.15 (m, 1H, H-4), 3.08 (d, J = 13.4 Hz, 1H, H-8), 
3.18 (d, J = 13.4 Hz, 1H, H-8), 3.20 (s, 1H, OH). 13C NMR spectrum (100 MHz) in CDCl3, 
δ (ppm): 14.0 (CH3 heptynyl-7), 19.0 (CH2 heptynyl-3), 21.0 and 21.1 (C-9 and C-10), 
22.2 (CH2 heptynyl-6), 23.8 (C-5), 27.9 (C-6), 27.9 (CH2 heptynyl-4), 31.2 (CH2 heptynyl-
5), 47.4 (C-7), 50.0 (C-8), 55.9 (C-4), 64.2 (C-1), 73.0 (C-3), 76.3 and 90.2 (C≡C), 194.4 
(C-2). 
c) Reaction with 1-adamantylacetylene: 
Yield is 88 %, 12c:13c = 70:30. Anal. Calcd for C22H29NO3S: C, 68.18; H, 7.54; N, 3.61, 
S, 8.27.  Found: C, 68.00; H, 7.89; N, 3.53; S, 8.11. EI-MS, m/z: (M is 387.545) 388 [M + 
H]+, 324 [M - SO2]+, 135 [adamantyl]+.  
(3aS,7aS)-7a-(1-Adamantylethynyl)-8,8-dimethyl-7-oxo-1,4,5,6,7,7a-hexahydro-3H-
3a,6-methano-2,1-benzisothiazole 2,2-dioxide (12c).  
Colourless solid. TLC on SiO2, Rf = 0.48 (eluent CH2Cl2/Et2O 9:1). IR spectrum (selected 
bands), cm-1: 3221 s ν(NH), 2230 w ν(C≡C), 1764 s ν(C=O), 1316 and 1145 s ν (SO2). 1H 
NMR spectrum (400 MHz) in CDCl3, δ (ppm): 1.09 (s, 3H, H-10), 1.27 (s, 3H, H-9), 1.64 
(m, br., 6H), 1.86 (m, br., 6H) and 2.00 (m, br., 3H)(adamantyl), 1.78 (m, 1H, H-5endo), 
2.01 (m, 1H, H-6), 2.06 (m, 1H, H-5exo), 2.42 (m, 1H, H-6), 2.40 (d, J = 5.0 Hz, 1H, H-4), 
3.37 (“s”, 2H, H-8), 4.73 (s, br., 1H, NH). 13C NMR spectrum (100 MHz) in CDCl3, δ 
(ppm): 19.8 (C-10), 21.8 (C-9), 22.7 (C-5), 27.7 (ada CH), 29.2 (C-6), 29.9 (ada Cq), 36.2 
and 42.3 (ada CH2), 45.0 (C-7), 49.6 (C-8), 56.7 (C-1), 58.5 (C-4), 64.9 (C-2), 74.4 and 
99.0 (C≡C), 206.2 (C-3).  
(3aS,7R)-7-(1-Adamantylethynyl)-7-hydroxy-8,8-dimethyl-4,5,6,7-tetrahydro-3H-
3a,6-methano-2,1-benzisothiazole 2,2-dioxide (13c).  
Colourless solid. TLC on SiO2, Rf = 0.45 (eluent CH2Cl2/Et2O 9:1). IR spectrum (selected 
bands), cm-1: 3480 s ν(OH), 2230 w ν(C≡C), 1652 s ν (C=N), 1326 and 1158 s ν (SO2). 1H 
NMR spectrum (400 MHz) in CDCl3, δ (ppm): 1.00 (s, 3H) and 1.09 (s, 3H)(H-9 and H-
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10), 1.66 (m, 1H, H-6), 1.90 (m, 1H, H-5exo), 1.93 (m, 1H, H-6), 2.03 (m, 1H, H-5endo), 
1.62 (m, br., 6H), 1.88 (m, br., 6H) and 2.01 (m, br., 3H)(adamantyl), 2.17 (d, J = 3.8 Hz, 
1H, H-4), 3.13 (d, J = 13.4 Hz, 1H, H-8), 3.21 (d, J = 13.4 Hz, 1H, H-8), 3.18 (s, br., OH). 
13C NMR spectrum (100 MHz) in CDCl3, δ (ppm): 21.0 and 21.1 (C-9 and C-10), 24.0 (C-
5), 27.6 (ada CH), 28.0 (C-6), 29.8 (ada Cq), 36.2 and 42.0 (ada CH2), 47.4 (C-7), 50.1 (C-
8), 55.9 (C-4), 64.2 (C-1), 73.0 (C-3), 76.1 and 98.3 (C≡C), 194.9 (C-2). 
d) Reaction with 1-methoxy-1-ethynyl-cyclohexane: 
Yield is 67 %, 12d:13d = 50:50. Anal. Calcd for C19H27NO4S: C, 62.44; H, 7.45; N, 3.83, 
S, 8.77.  Found: C, 61.98; H, 7.52; N, 3.77; S, 8.89. EI-MS, m/z: (M is 365.495) 366 [M + 
H]+, 348 [M - H2O]+, 334 [M - OMe]+, 270 [M - OMe - SO2]+.   
(3aS,7aS)-7a-(1-Methoxycyclohexyl)ethynyl-8,8-dimethyl-7-oxo-1,4,5,6,7,7a-
hexahydro-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide (12d).  
Colourless solid. TLC on SiO2, Rf = 0.50 (eluent CH2Cl2/Et2O 9:1). IR spectrum (selected 
bands), cm-1: 3217 s ν(NH), 2228 w ν (C≡C), 1766 s ν(C=O), 1317 and 1143 s ν (SO2). 1H 
NMR spectrum (400 MHz) in CDCl3, δ (ppm): 0.98 (s, 3H, H-10), 1.16 (s, 3H, H-9), 1.65 
(m, 1H, H-5 endo), 1.93 (m, 1H, H-6), 1.97 (m, 1H, H-5 exo), 2.30 (m, 1H, H-6), 2.33 (d, J 
= 4.8 Hz, 1H, H-4), 3.22 (s, 3H, OMe), 3.26 (“s”, 2H, H-8), 1.18 (m, 2H), 1.38 (m, 2H), 
1.47 (m, 2H), 1.55 (m, 2H), 1.80 (m, 2H)(cyclohexyl), 5.01 (s, br., 1H, NH). 13C NMR 
spectrum (100 MHz) in CDCl3, δ (ppm): 19.7 (C-10), 22.0 (C-5), 22.6 (C-9), 29.1 (C-6), 
45.1 (C-7), 49.6 (C-8), 51.0 (OMe), 56.8 (C-1), 58.3 (C-4), 64.7 (C-2), 205.4 (C-3), 22.7, 
25.3 and 36.4 (cyclohexyl CH2), 74.2 (cyclohexyl Cq), 81.4 and 91.5 (C≡C).  
 (3aS,7R)-7-(1-Methoxycyclohexyl)ethynyl-8,8-dimethyl-7-hydroxy-4,5,6,7-
tetrahydro-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide (13d).   
Colourless solid. TLC on SiO2, Rf = 0.48 (eluent CH2Cl2/Et2O 9:1). IR spectrum (selected 
bands), cm-1: 3444 s ν(OH), 2228 w ν (C≡C), 1655 s ν (C=N), 1322 and 1160 s ν (SO2). 
1H NMR spectrum (400 MHz) in CDCl3, δ (ppm): 0.99 (s, 3H) and 1.00 (s, 3H)(H-9 and 
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H-10), 1.68 (m, 1H, H-6), 1.90 (m, 1H, H-5 exo), 1.93 (m, 1H, H-6), 2.03 (m, 1H, H-5 
endo), 2.17 (d, J = 3.8 Hz, 1H, H-4), 3.02 (d, J = 13.5 Hz, 1H, H-8), 3.12 (d, J = 13.4 Hz, 
1H, H-8), 3.22 (s, 3H, OMe), 1.17 (m, 2H), 1.39 (m, 2H), 1.48 (m, 2H), 1.54 (m, 2H), 1.82 
(m, 2H)(cyclohexyl), 3.23 (s, br., 1H, OH). 13C NMR spectrum (100 MHz) in CDCl3, δ 
(ppm): 21.0 and 21.1 (C-9 and C-10), 23.9 (C-5), 28.0 (C-6), 47.5 (C-7), 49.9 (C-8), 51.0 
(OMe), 55.8 (C-4), 64.1 (C-1), 72.9 (C-3), 194.5 (C-2), 22.8, 25.2 and 36.5 (cyclohexyl 
CH2) and 74.0 (cyclohexyl Cq), 83.0 and 90.7 (C≡C). 
Reduction pathway  
(3aS,7aS)-8,8-Dimethyl-7-oxo-1,4,5,6,7,7a-hexahydro-3H-3a,6-methano-2,1-
benzisothiazole 2,2-dioxide (3-oxo-camphorsultam) (14). 
To a well stirred solution of 3-oxo-camphorsulfonimide (3) (2.29 g, 10 mmol) in acetic 
acid (20 ml) and hot water (150 ml), zinc powder (1.4 g, 20 mmol) was added in small 
portions over a period of 1h. The reaction mixture was kept at 80 oC for another hour. 
Then, the excess of zinc powder was filtered off and the solvent was evaporated. The 
resulting white solid was extracted with chloroform to separate the organic material from 
the insoluble zinc salts. The filtrate was evaporated and the residue recrystallized from 
chloroform/diethyl ether.   
Yield is 65 %. Anal. Calcd for C10H15NO3S: C, 52.38; H, 6.59; N, 6.11, S, 13.98.  Found: 
C, 52.24; H, 6.51; N, 6.19; S, 14.11. EI-MS, m/z: (M is 229.300) 229 [M]+, 201 [M - CO]+, 
132 [M - 97]+.  M.p. 170 oC.  IR spectrum (selected bands), cm-1: 3180 w ν(N−H), 1760 s 
ν(C=O), 1310 and 1130 s ν(SO2). 1H NMR spectrum (400 MHz) in CDCl3, δ (ppm): 1.03 
(s, 3H) and 1.15 (s, 3H)(9-H and 10-H), 1.73 (m, 1H), 1.84 (m, 1H) and 2.05-2.20 (m, 
2H)(5-H and 6-H), 2.36 (d, J = 3.8 Hz, 1H, 4-H), 3.32 (d, J = 13.8 Hz, 1H) and 3.34 (d, J = 
13.8 Hz, 1H)(8-H), 3.58 (d, J = 4.3 Hz, 1H, 2-H), 5.57 (d, J = 4.3 Hz, 1H, NH). 13C NMR 
spectrum (100 MHz) in CDCl3, δ (ppm): 18.8 and 20.9 (C-9 and C-10), 20.4 and 30.85 (C-
5 and C-6), 45.7 (C-7), 49.4 (C-8), 52.4 (C-1), 57.6 (C-4), 65.0 (C-2), 209.7 (C-3).  
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(3aS,7R,7aS)-7-Hydroxy-8,8-dimethyl-7-phenylethynyl-1,4,5,6,7,7a-hexahydro-3H-
3a,6-methano-2,1-benzisothiazole 2,2-dioxide (3-exo-hydroxy-3-endo-phenylethinyl-
camphorsultam) (15). 
Similar as described in [33], a solution of phenylacetylene (1.1 g, 10.8 mmol) in dry 
diethyl ether (10 ml) was cooled in an ice bath. Butyl lithium (1.6M in hexanes, 6.25 ml, 
10 mmol) was added and the reaction mixture was left at room temperature for 30 min, 
before it was added dropwise to a suspension of 3-oxo-camphersultam (14) (1.15 g, 5 
mmol) in dry diethyl ether (10 ml). The reaction mixture was stirred overnight, water (10 
ml) was added and the organic phase was separated. The aqueous phase was extracted 
twice with dichloromethane, and the combined organic phases were dried with Na2SO4. 
After chromatography on SiO2 (eluent CH2Cl2/Et2O 9:1) the compound was obtained as a 
white solid. 
Yield is 72 %. Anal. Calcd for C18H21NO3S: C, 65.23; H, 6.39; N, 4.23, S, 9.67.  Found: C 
65.17; H, 6.44; N, 4.11; S, 9.73. CI-MS, m/z: (M is 331.437) 332 [M + H]+. M.p. 74-76 oC. 
TLC on SiO2, Rf = 0.48 (eluent CH2Cl2/Et2O 9:1). IR spectrum (selected bands), cm-1: 
3292 s ν(N−H), 2218 w ν(C≡C), 1308 and 1133 s ν(SO2). 1H NMR spectrum (400 MHz) 
in CDCl3, δ (ppm): 0.96 (s, 3H) and 1.35 (s, 3H)(9-H, 10-H), 1.45 (m, 1H), 1.86-1.94 (m, 
2H) and 2.02 (m, 1H)(5-H and 6-H), 2.16 (d, J = 4.8 Hz, 1H, 4-H), 3.07 (s, br., 1H, OH), 
3.19 (s, 2H, 8-H), 3.67 (d, J = 9.9 Hz, 2-H), 4.86 (d, J = 9.9 Hz, NH), 7.33 (m, 3H) and 
7.43 (m, 2H)(Ph). 13C NMR spectrum (100 MHz) in CDCl3, δ (ppm): 22.1 and 22.8 (C-9 
and C-10), 23.8 and 30.3 (C-5 and C-6), 48.9 (C-7), 51.2 (C-8), 55.8 (C-4), 57.5 (C-1), 
73.6 (C-2), 76.0 (C-3), 85.3 and 90.9 (C≡C), 121.7, 128.4, 128.8 and 131.7 (Ph). 
Acetal pathway: 
(3aS,7aS)-7,7-Dimethoxy-8,8-dimethyl-7a-phenylethynyl-1,4,5,6,7,7a-hexahydro-3H-
3a,6-methano-2,1-benzisothiazole 2,2-dioxide (2-endo-phenylethinyl-3,3-dimethoxy-
camphorsultam) (17a).  
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Similar as described in [33], a solution of the phenylacetylene (520 mg, 5.1 mmol) in dry 
diethyl ether (10 ml) was cooled in an ice bath. Butyl lithium (1.6M in hexanes, 6.25 ml, 5 
mmol) was added and the reaction mixture was left at room temperature for 30 min, before 
it was added dropwise to a suspension of 3,3-dimethoxy-camphorsulfonylimine (16) [18] 
(1.37 g, 5 mmol) in dry diethyl ether (10 ml). The reaction mixture was stirred overnight, 
water (10 ml) was added and the organic phase was separated. The aqueous phase was 
extracted twice with dichloromethane, and the combined organic phases were dried with 
Na2SO4. After chromatography on SiO2 (eluent CH2Cl2/Et2O 9:1) the compound was 
obtained as a colourless solid.   
Yield is 82 %. Anal. Calcd for C20H25NO4S: C, 63.98; H, 6.71; N, 3.73, S, 8.54.  Found: C 
64.08; H, 6.79; N, 3.67; S, 8.66.  EI-MS, m/z: (M is 375.491) 375 [M]+, 360 [M - NH]+, 
345 [M - OMe]+, 311 [M - SO2]+, 183 [M - 192]+, 101 [PhCCH]+, 77 [Ph]+. M.p. 217 oC. 
TLC on SiO2, Rf = 0.31 (eluent CH2Cl2). IR spectrum (selected bands), cm-1: 3348 ν(NH), 
2231 w ν(C≡C), 1307 and 1125 s ν (SO2). 1H NMR spectrum (500 MHz) in CDCl3, δ 
(ppm): 0.99 (s, 3H) and 1.43 (s, 3H)(9-H, 10-H), 1.72-1.82 (m, 2H), 2.06 (m, 1H) and 2.36 
(m, 1H)(5-H and 6-H), 2.23 (d, J = 4.8Hz, 1H, 4-H), 3.22 (d, J = 14.0 Hz, 1H) and 3.27 (d, 
J = 14.0 Hz, 1H)(8-H), 3.32 (s, 3H) and 3.41 (s, 3H)(2 OMe), 5.20 (s, 1H, NH), 7.27-7.33 
(m, 3H) and 7.43-7.49 (m, 2H)(Ph). 13C NMR spectrum (125 MHz) in CDCl3, δ (ppm): 
21.7 and 23.1 (C-9 and C-10), 20.5 and 28.6 (C-5 and C-6), 46.6 (C-7), 49.3 (C-4), 50.0 
(C-8), 50.9 and 51.2 (2 OMe), 63.4 (C-1), 70.8 (C-2), 86.7 and 88.2 (C≡C), 108.7 (C-3), 
122.4, 128.1, 128.3 and 131.5 (Ph).  
(3aS,7aS)-7,7-Diethoxy-8,8-dimethyl-7a-phenylethynyl-1,4,5,6,7,7a-hexahydro-3H-
3a,6-methano-2,1-benzisothiazole 2,2-dioxide (2-endo-phenylethinyl-3,3-diethoxy-
camphorsultam) (17a’). 
The compound was prepared in analogy to 17a from 3,3-diethoxy-camphorsulfonylimine 
(16’) [18] as a starting material. Yield is 77 %. Anal. Calcd for C22H29NO4S: C, 65.48; H, 
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7.24; N, 3.47, S, 7.93.  Found: C 65.08; H, 7.11; N, 3.55; S, 8.11. EI-MS, m/z: (M is 
403.545) 404 [M]+, 359 [M - OEt]+, 340 [M - SO2]+, 101 [PhCCH]+, 77 [Ph]+. TLC on 
SiO2, Rf = 0.33 (eluent CH2Cl2). IR spectrum (selected bands), cm-1: 3411 ν(NH), 2233 w 
ν(C≡C), 1305 and 1123 s ν (SO2). 1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 1.23 
(t, 7.2 Hz, 6H, 2 OEt), 1.00 (s, 3H) and 1.43 (s, 3H)(9-H, 10-H), 1.73-1.84 (m, 2H), 2.06 
(m, 1H) and 2.37 (m, 1H)(5-H and 6-H), 2.25 (d, J = 4.8Hz, 1H, 4-H), 3.22 (d, J = 14.0 Hz, 
1H) and 3.26 (d, J = 14.0 Hz, 1H)(8-H), 3.44 (m, 1H), 3.57 (m, 2H) and 3.95 (m, 1H)(2 
OEt), 5.19 (s, 1H, NH), 7.29-7.33 (m, 3H) and 7.45-7.48 (m, 2H)(Ph). 13C NMR spectrum 
(125 MHz) in CDCl3, δ (ppm): 14.2 and 14.6 (2 OEt), 21.7 and 23.2 (C-9 and C-10), 20.5 
and 28.6 (C-5 and C-6), 46.5 (C-7), 49.5 (C-4), 50.0 (C-8), 58.5 and 59.1 (2 OEt), 63.3 (C-
1), 70.7 (C-2), 86.8 and 88.2 (C≡C), 108.7 (C-3), 122.4, 128.0, 128.1 and 131.4 (Ph).  
(3aS,7aS)-7,7-Dimethoxy-8,8-dimethyl-7a-(1-heptynyl)-1,4,5,6,7,7a-hexahydro-3H-
3a,6-methano-2,1-benzisothiazole 2,2-dioxide (2-endo-heptynyl-3,3-dimethoxy-
camphorsultam) (17b).   
The compound was prepared in analogy to 17a by reaction of 3,3-dimethoxy-
camphorsulfonylimine (16) with 1-heptynyl lithium. Yield 41 %. Accurate EI-MS, m/z: 
Calcd for C19H32NO4S [M + H]+: 370.2040. Found: 370.2047 (Delta [mmu] -0.7). EI-MS, 
m/z: 370 [M + H]+, 338 [M − MeOH]+, 306 [M − SO2]+, 279 [M − MeOH − SO2]+. IR 
spectrum (selected bands), cm−1: 3360 ν(NH), 2252 w ν(C≡C), 1306 and 1123 s ν(SO2). 
1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 0.90 (t, 3H, J = 7.2 Hz, 3H, heptynyl-7), 
0.98 (s, 3H, H-10), 1.33 (m, 2H, heptynyl-6), 1.41 (m, 2H, heptynyl-5), 1.40 (s, 3H, H-9), 
1.53 (quint., J = 7.3 Hz, 2H, heptynyl-4), 1.73 (m, 2H, H-5 exo and H-6 exo), 1.98 (m, 1H, 
H-5 endo), 2.27 (d, J = 5.0 Hz, 1H, H-4), 2.28 (t, J = 7.3 Hz, 2H, heptynyl-13), 2.31 (1H, 
m, H-6 endo), 3.18 (d, J = 14.2 Hz, 1H, H-8), 3.19 (d, J = 14.2 Hz, 1H, H-8), 3.28 (s, 3H, 
OMe exo), 3.35 (s, 3H, OMe endo),  5.01 (s, br., 1H. NH). 13C NMR spectrum (125 MHz) 
in CDCl3, δ (ppm): 14.2 (CH3, heptynyl-7), 19.2 (CH2, heptynyl-3), 20.8 (CH2, C-5), 22.2 
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(CH3, C-9), 22.3 (CH2, heptynyl-6), 23.6 (CH3, C-10), 28.2 (CH2, heptynyl-4), 29.0 (CH2, 
C-6), 31.2 (CH2, heptynyl-5), 46.7 (Cq, C-7), 49.7 (CH, C-4), 50.4 (CH2, C-8), 51.2 (CH3, 
OMe exo), 51.5 (CH3, OMe endo), 63.7 (Cq, C-1), 70.9 (Cq, C-2), 77.7 (Cq) and 89.7 
(Cq)(C≡C), 108.8 (Cq, C-3). 
(3aS,7aS)-8,8-Dimethyl-7-oxo-7a-phenylethynyl-1,4,5,6,7,7a-hexahydro-3H-3a,6-
methano-2,1-benzisothiazole 2,2-dioxide (12a).   
To a solution of 17a or 17a’ (4 mmol) in acetone (5 ml), conc. HCl (0.05 ml) was added 
and the reaction mixture was stirred at room temperature overnight. After evaporation of 
the solvent and chromatography (SiO2, CH2Cl2/Et2O 9:1), the compound was obtained as a 
colourless solid. Yield is 91 % (from 17a); 82 % (from 17a’). For analytical data of 
product 12a, see above.  
(3aS,7aS)-8,8-Dimethyl-7-oxo-7a-(1-heptynyl)-1,4,5,6,7,7a-hexahydro-3H-3a,6-
methano-2,1-benzisothiazole 2,2-dioxide (12b).  
This compound was prepared in analogy to 12a from 17b as starting material. Colourless 
oil. Yield 81 %. For analytical data of product 12b, see above.  
(3aS,7R,7aS)-7-Hydroxy-8,8-dimethyl-7a-phenylethynyl-1,4,5,6,7,7a-hexahydro-3H-
3a,6-methano-2,1-benzisothiazole 2,2-dioxide (2-endo-phenylethinyl-3-exo-hydroxy-
camphorsultam) (18).  
A solution of 12a (200 mg, 0.61 mmol) in ethanol (5 ml) was cooled to 0 oC. Then, solid 
NaBH4 (28 mg, 0.74 mmol) was added, the ice bath was removed and the reaction mixture 
stirred at room temperature for 15 min. Water (5 ml) was added and the reaction mixture 
was heated to reflux for 15 min. The mixture was extracted with diethylether (5 ml) and 
then with CH2Cl2 (2 × 3 ml) and the organic phase was dried over MgSO4. After 
evaporation of the solvent and chromatography (SiO2, CH2Cl2/Et2O 9:1) the product was 
obtained as a colourless solid. 
 33 
Yield is 86 %. Accurate EI-MS, m/z: Calcd for C18H20NO3S [M - H]+: 330.1164. Found: 
330.1174 (Δ [mmu] –1.0). EI-MS, m/z: (M is 331.437) 331 [M]+, 330 [M - H]+, 267 [M - 
SO2]+, 102 [PhCCH]+. M.p. 202-203 oC. TLC on SiO2, Rf = 0.42 (CH2Cl2/Et2O 9:1). IR 
spectrum (selected bands), cm-1: 3524 and 3452 s ν(O−H), 3350 and 3297 ν(N−H), 2217 w 
ν(C≡C), 1305 and 1128 s ν(SO2). 1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 0.99 
(s, 3H, 9/10-H), 1.44 (s, 3H, 9/10-H), 1.34 (m, 1H, 5-H endo), 1.81 (m, 1H, 6-H endo), 
1.92 (m, 1H, 5-H exo), 2.23 (m, 1H, 6-H exo), 2.02 (d, J = 5.2 Hz, 1H, 4-H), 2.69 (d, J = 
6.0 Hz, 1H, OH), 3.32 (d, J = 13.6Hz, 1H, H-8), 3.40 (d, J = 13.6 Hz, 1H, H-8), 4.31 (d, J = 
6.4 Hz, 1H, H-3 endo), 4.97 (s, 1H, NH), 7.31 (m, 3H) and 7.44 (m, 2H)(Ph). 13C NMR 
spectrum (125 MHz) in CDCl3, δ (ppm): 22.8 (CH3) and 23.4 (CH3)(C-9,C-10), 24.4 (CH2, 
C-5), 28.5 (CH2, C-6), 49.4 (Cq, C-7), 51.3 (CH2, C-8), 51.4 (CH, C-4), 61.6 (Cq, C-1), 
68.7 (Cq, C-2), 85.6 (CH, C-3), 86.9 and 89.6 (C≡C), 122.3 (Cq), 128.5, 128.9 and 
132.1(CH)(Ph). 
Imine pathway: 
(3aS)-8,8-Dimethyl-7-(2-phenylethyl)imino-4,5,6,7-tetrahydro-3H-3a,6-methano-2,1-
benzisothiazole 2,2-dioxide (3-((2-phenylethyl)imino)-camphorsulfonylimine) (19) 
[40]. 
A solution of 3-oxo-camphorsulfonylimine (3) (10.6 g, 50 mmol) and 2-phenylethylamine 
(21.2 g, 175 mmol) in toluene (200 ml) was cooled to 0 oC. A solution of TiCl4 (6.5 g, 25 
mmol) in toluene (50 ml) was added dropwise. The reaction mixture was refluxed for 16 h 
and then cooled to room temperature. Chloroform (250 ml) was added and the mixture 
stirred for 2 h. After filtration, activated charcoal (2 g) was added to the filtrate. After 
stirring for 10 minutes, the charcoal was filtered off over a bed of Celite, the solvent was 
evaporated and the residual solid recrystallised from chloroform/diethyl ether.   
Yield is 61.7 %. Accurate EI-MS, m/z: Calcd for C18H22N2O2S [M]+: 330.1402. Found: 
330.1418 (Δ [mmu] –1.6). EI-MS, m/z: (M is 330.452) 330 [M]+, 266 [M - SO2]+, 105 
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[PhCH2CH2]+. M.p. 148-150 oC. TLC on SiO2, Rf = 0.66 (eluent ethyl acetate/hexane 2:1). 
IR spectrum (selected bands), cm-1: 1675 and 1647 s ν(C=N), 1336 and 1160 s ν(SO2). 1H 
NMR spectrum (500 MHz) in CDCl3, δ (ppm): 0.65 (s, 3H) and 1.01 (s, 3H)(9-H, 10-H), 
1.09 (m, 1H, H-5 endo), 1.77 (m, 1H, H-6 endo), 1.95 (m, 1H, H-5 exo), 2.06 (m, 1H, H-6 
exo), 2.85 (d, J = 4.8 Hz, H-4), 3.07 (d, J = 12.0 Hz, 1H) and 3.28 (d, J = 12.0 Hz, 1H)(H-
8), 3.09 (m, 2H, CH2Ph), 3.91 (m, 2H, CH2N=), 7.21 (m, 3H) and 7.26 (m, 2H)(Ph). 13C 
NMR spectrum (125 MHz) in CDCl3, δ (ppm): 18.3 and 19.4 (C-9 and C-10), 23.1 (C-5), 
28.3 (C-6), 36.3 (CH2Ph), 46.0 (C-7), 49.6 (C-4), 49.7 (C-8), 57.2 (CH2N=), 62.6 (C-1), 
126.4, 128.4, 128.9 and 139.4 (Ph), 167.0 (C-3), 185.0 (C-2). 
(3aS,7aS)-8,8-Dimethyl-7-(2-phenylethyl)imino-7a-phenylethynyl-1,4,5,6,7,7a-
hexahydro-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide (20). 
Similar as described in [33], a solution of phenylacetylene (520 mg, 5.1 mmol) in dry 
diethyl ether (10 ml) was cooled in an ice bath. Butyl lithium (1.6M in hexanes, 6.25 ml, 5 
mmol) was added dropwise and the reaction mixture was left at room temperature for 30 
min, before it was added dropwise to a suspension of 3-((2-phenylethyl)imino)-
camphorsulfonylimine (19) (1.65 g, 5 mmol) in dry diethyl ether (10 ml). The reaction 
mixture was stirred overnight, water (10 ml) was added and the organic phase was 
separated. The aqueous phase was extracted twice with dichloromethane, and the 
combined organic phases were dried with Na2SO4. After chromatography on SiO2 (eluent 
CH2Cl2/Et2O 9:1) the compound was obtained as a pale yellow solid.   
Yield is 78 %. Accurate EI-MS, m/z: Calcd for C26H27N2O2S [M - H]+: 431.1793. Found: 
431.1793 (Δ [mmu] 0.0). EI-MS, m/z: (M is 432.589) 432 [M]+, 431 [M – H]+, 368 [M – 
SO2]+, 328 [M – PhCH=CH2]+, 264 [M – SO2 – PhCH=CH2]+, 105 [PhCH2CH2]+, 102 
[PhCCH]+. M.p. 87-88 oC. TLC on SiO2, Rf = 0.56 (eluent ethyl acetate/hexane 2:1). IR 
spectrum (selected bands), cm-1: 3195 s ν(N−H), 2221 w ν(C≡C), 1695 s ν(C=N), 1309 
and 1144 s ν(SO2). 1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 1.00 (s, 3H, H-10), 
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1.14 (s, 3H, H-9), 1.02 (m, 1H, H-5 endo), 1.73 (m, 1H, H-5 exo), 1.91 (td, J = 12.0 Hz, J = 
6.0 Hz, 1H, H-6 exo), 2.36 (m, 1H, H-6 endo), 2.91 (m, 1H) and 3.00 (m, 1H)(CH2Ph), 
2.71 (d, J = 4.6 Hz, 1H, H-4), 3.30 (d, J = 12.2 Hz, 1H, H-8 syn), 3.37 (d, J = 12.2 Hz, 1H, 
H-8 anti), 3.67 (m, 1H) and 3.76 (m, 1H)(CH2N=), 7.21 (m, 3H) and 7.26 (m, 2H)(CH2Ph), 
7.15 (m, 1H), 7.30 (m, 2H) and 7.47 (d, 8.2 Hz, 2H)(PhC≡C). 13C NMR spectrum (125 
MHz) in CDCl3, δ (ppm): 20.2 (C-10), 22.6 (C-5), 22.8 (C-9), 29.5 (C-6), 36.8 (CH2Ph), 
46.7 (C-7), 48.9 (C-4), 50.0 (C-8), 55.4 (CH2N=), 57.6 (C-1), 66.1 (C-2), 87.3 and 88.0 
(C≡C), 122.5, 126.5, 128.4 and 128.6 (CH2Ph), 128.9, 129.4, 132.2 and 140.0 (PhC≡C), 
175.8 (C-3). 
(3aS,7aS)-8,8-Dimethyl-7-oxo-7a-phenylethynyl-1,4,5,6,7,7a-hexahydro-3H-3a,6-
methano-2,1-benzisothiazole 2,2-dioxide (12a).  
To a suspension of 20 (107 mg, 0.25 mmol) in water (5 ml), conc. HCl (0.5 ml) was added 
and the reaction mixture was refluxed overnight. The reaction mixture was left to cool and 
the crude product was collected by filtration. The product was purified by chromatography 
(SiO2, CH2Cl2/Et2O 9:1) and obtained as a colourless solid. Yield is 38 %. For analytical 
data of product 12a, see above. 
Bis-Alkyne Derivatives: 
(3aS,7R,7aS)-8,8-Dimethyl-7-heptynyl-7-hydroxy-7a-phenylethynyl-1,4,5,6,7,7a-
hexahydro-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide (2-endo-phenylethinyl-
3-endo-heptynyl-3-exo-hydroxy-camphorsultam) (21a).   
Similar as described in [33], a solution of 1-heptyne (395 mg, 4.1 mmol) in dry diethyl 
ether (5 ml) was cooled in an ice bath. Butyl lithium (1.6M in hexanes, 2.5 ml, 4 mmol) 
was added and the reaction mixture was left at room temperature for 30 min, before it was 
added dropwise to a suspension of 12a (660 mg, 2 mmol) in dry diethyl ether (5 ml). The 
reaction mixture was refluxed overnight, water (10 ml) was added and the organic phase 
was separated. The aqueous phase was extracted twice with dichloromethane, and the 
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combined organic phases were dried with Na2SO4. After chromatography on SiO2 (eluent 
CH2Cl2/Et2O 9:1) the compound was obtained as a white solid. 
Yield 76 %. Elemental analysis calculated for C25H31NO3S: C 70.55; H 7.34; N 3.29; 
found: C 70.44; H 7.69; N 3.10. EI-MS: (M = 425.595) 426 [M + H]+, 408 [M − H2O]+, 
330 [M − heptyne]+, 324 [M − PhC≡CH]+. IR spectrum (selected bands), cm−1: 3411 s 
ν(OH), 3323 ν(NH), 2233 w ν(C≡C), 1335 and 1149 s ν(SO2). 1H NMR spectrum (500 
MHz) in CDCl3, δ (ppm): 0.73 (t, 7.5 Hz, 3H, heptynyl-7), 0.95 (s, 3H, H-10), 1.13 (m, 
2H, heptynyl-6), 1.22 (m, 2H, heptynyl-5), 1.38 (m, 2H, heptynyl-4), 1.41 (s, 3H, H-9), 
1.71 (m, 1H, H-6 exo), 1.79 (m, 1H, H-5 exo), 1.97 (m, 1H, H-5 endo), 2.03 (d, J = 5.1 
Hz, 1H, H-4), 2.16 (t, J = 7.2 Hz, 2H, heptynyl-3), 2.19 (m, 1H, H-6 endo), 2.87 (s, br., 
1H, OH), 3.25 (d, J = 13.5 Hz, 1H, H-8 syn), 3.30 (d, J = 13.5 Hz, 1H, H-8 anti), 5.08 (s, 
1H, NH), 7.22 (m, 3H, m- and p-Ph), 7.40 (m, 2H, o-Ph). 13C NMR spectrum (125 MHz) 
in CDCl3, δ (ppm): 14.1 (CH3, heptynyl-7), 19.0 (CH2, heptynyl-3), 22.3 (CH2, heptynyl-
6), 23.8 (CH3, C-9), 24.2 (CH2, C-5), 24.3 (CH3, C-10), 28.4 (CH2, heptynyl-4), 28.6 
(CH2, C-6), 31.4 (CH2, heptynyl-5), 49.2 (Cq, C-7), 51.6 (CH2, C-8), 56.7 (CH, C-4), 62.8 
(Cq, C-1), 73.1 (Cq, C-2), 82.2 (Cq, C-3), 80.7, 88.0, 89.7 and 90.2 (Cq, C≡C), 122,8 (Cq, 
Ph), 128.4 (CH, m-Ph), 128.8 (CH, p-Ph), 131.9 (CH, o-Ph). 
 (3aS,7R,7aS)-8,8-Dimethyl-7a-heptynyl-7-hydroxy-7-phenylethynyl-1,4,5,6,7,7a-
hexahydro-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide (2-endo-heptynyl-3-
endo-phenylethinyl-3-exo-hydroxy-camphorsultam) (21b). 
This compound was prepared in analogy to 21a from 12b and phenylethynyl lithium as 
starting materials.  
Yield 73 %. Accurate EI-MS, m/z: Calcd for C25H32NO3S [M + H]+: 426.2097. Found: 
426.2095 (Δ [mmu] -0.2). EI-MS, m/z: 426 [M + H]+, 408 [M − H2O]+, 362 [M − SO2]+, 
345 [M − H2O − SO2]+. IR spectrum (selected bands), cm−1: 3414 ν(OH), 3322 s ν(NH), 
2235 w ν(C≡C), 1330 and 1128 s ν(SO2). 1H NMR spectrum (500 MHz) in CDCl3, δ 
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(ppm): 0.78 (t, 7.3 Hz, 3H, heptynyl-7), 1.02 (s, 3H, H-10), 1.17 (m, 2H, heptynyl-6), 1.28 
(m, 2H, heptynyl-5), 1.48 (s, 3H, H-9), 1.54 (m, 2H, heptynyl-4), 1.76 (td, J = 12.2 Hz, J = 
5.0 Hz, 1H, H-6 exo), 1.89 (m, 1H, H-5 exo), 2.04 (ddd, J = 13.8 Hz, J = 9.2 Hz, J = 4.8 
Hz, 1H, H-5 endo), 2.18 (d, J = 4.9 Hz, 1H, H-4), 2.22 (m, 1H, H-6 endo), 2.27 (t, J = 7.2 
Hz, 2H, heptynyl-3), 3.16 (s, br., 1H, OH), 3.29 (d, J = 13.7 Hz, 1H, H-8 syn), 3.33 (d, J = 
13.7 Hz, 1H, H-8 anti), 5.08 (s, 1H, NH), 7.31 (m, 3H, m- and p-Ph), 7.45 (m, 2H, o-Ph). 
13C NMR spectrum (125 MHz) in CDCl3, δ (ppm): 14.1 (CH3, heptynyl-7), 19.2 (CH2, 
heptynyl-3), 22.3 (CH2, heptynyl-6), 23.9 (CH3, C-9), 24.1 (CH2, C-5), 24.3 (CH3, C-10), 
28.4 (CH2, heptynyl-4), 28.6 (CH2, C-6), 31.3 (CH2, heptynyl-5), 49.1 (Cq, C-7), 51.5 
(CH2, C-8), 56.7 (CH, C-4), 62.2 (Cq, C-1), 72.9 (Cq, C-2), 78.4 (Cq, heptynyl-1), 82.4 (Cq, 
C-3), 88.1 (Cq) and 89.9 (Cq)(PhC≡C), 91.8 (Cq, heptynyl-2), 122,5 (Cq, Ph), 128.6 (CH, 
m-Ph), 128.9 (CH, p-Ph), 131.9 (CH, o-Ph). 
Platinum-catalysed Cycloisomerisations:   
 A solution of 21a (150mg, 0.35 mmol) and PtCl2(PhCN)2 (8 mg, 0.017 mmol, 5 mol %) 
in CHCl3 (2 ml) was heated to 60 oC overnight. Alternatively, the reaction mixture was 
heated under microwave irradiation to 80 oC for 30 min in a sealed vial. The initial pale 
yellow colour of the solution changed to orange-brownish. The solvent was evaporated 
and the residue was purified by column chromatography on SiO2 (eluent CH2Cl2/Et2O, 
gradient ratios 10:0, 10:1, 10:2, 10:5).  
(2S, 3aS)-10-Benzoyl-11,11-dimethyl-9-pentyl-4,5,6,7-tetrahydro-1H,3H-3a,6-
methanocyclonona[2,1-c]isothiazol-7-one 2-oxide (22a).  
Yield 67 %. Elemental analysis calculated for C25H31NO3S: C 70.55; H 7.34; N 3.29; 
found: C 70.10; H 7.19; N 3.26. Accurate EI-MS, m/z: Calcd for C25H32NO3S [M + H]+: 
426.2097. Found: 426.2091 (Δ [mmu] –0.6). EI-MS, m/z: 426 [M + H]+, 410 [M − NH3]+, 
377 [M − SO]+. IR spectrum (selected bands), cm−1: 3110 w ν(N-H····O=), 1680 and 1611 
s ν(C=O), 1533 s ν(C=C), 1098 m ν(SO). 1H NMR spectrum (500 MHz) in CDCl3, δ 
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(ppm): 0.76 (t, J = 7.1 Hz, 3H, pentyl-5), 0.99 (m. 2H, pentyl-3), 1.08 (m, 2H, pentyl-4), 
1.30 (m, 2H, pentyl-2), 1.32 (s, 3H, H-10), 1.35 (s, 3H, H-9), 1.70 (m, 1H, pentyl-1), 1.76 
(m, 1H, pentyl-1), 1.97 (m, 1H, H-5 endo), 2.15 (m, 1H, H-6 exo), 2.22 (m, 1H, H-5 exo), 
2.62 (d, J = 6.1 Hz, 1H, H-4), 2.74 (m, 1H, H-6 endo), 3.08 (d, J = 14.1Hz, 1H, H-8 anti), 
3.50 (d, J = 14.1 Hz, 1H, H-8 syn), 5.94 (s, 1H, =CH), 7.38 (t, J = 7.2 Hz, 2H, m-Ph), 7.45 
(t, J = 7.4Hz, 1H, p-Ph), 7.65 (d, J = 7.8 Hz, 2H, o-Ph), 11.97 (s, 1H, NH). 13C NMR 
spectrum (125 MHz) in CDCl3, δ (ppm): 14.1 (CH3, pentyl-5), 22.0 (CH3, C-9), 22.4 
(CH2, pentyl-4), 25.4 (CH2, C-5), 27.6 (CH2, pentyl-2), 28.9 (CH3, C-10), 31.5 (CH2, 
pentyl-3), 35.6 (CH2, C-6), 39.4 (CH2, pentyl-1), 47.1 (Cq, C-7), 60.3 (CH2, C-8), 61.5 
(Cq, C-1), 66.8 (CH, C-4), 109.0 (Cq, C2−C=), 128.27 (CH) and 128.28 (CH)(o- and m-
Ph), 129.3 (CH, =CH), 131.8 (CH, p-Ph), 138.4 (Cq, HC=C), 140.5 (Cq, Ph), 163.4 (Cq, C-
2), 198.3 (Cq, Ph-C=O), 210.8 (Cq, C-3). 
(2S, 3aS)-11,11-Dimethyl-10-(1-oxohexyl)-9-phenyl-4,5,6,7-tetrahydro-1H,3H-3a,6-
methanocyclonona[2,1-c]isothiazol-7-one 2-oxide (22b).  
This compound was prepared in analogy to 22a from 21b as starting material. The 
reaction provided 22b and 23 as a 1:1 mixture. These products were separated by column 
chromatography on SiO2 (eluent ethyl acetate/hexane 1:1). 
Yield 37 %. Elemental analysis calculated for C25H31NO3S: C 70.55; H 7.34; N 3.29; 
found: C 70.29; H 7.24; N 3.23. Accurate EI-MS, m/z: Calcd for C25H32NO3S [M + H]+: 
426.2093. Found: 426.2091 (Δ [mmu] –0.4). EI-MS, m/z: 426 [M + H]+, 377 [M − SO]+. 
Rf = 0.35 (eluent ethyl acetate/hexane 1:1). IR spectrum (selected bands), cm−1: 3105 w 
ν(N-H····O=), 1695 and 1623 s ν(C=O), 1533 s ν(C=C), 1100 m ν(SO). 1H NMR 
spectrum (500 MHz) in CDCl3, δ (ppm): 0.75 (t, J = 7.2 Hz, 3H, pentyl-5), 0.96 (m. 2H, 
pentyl-3), 1.10 (m, 2H, pentyl-4), 1.13 (m, 1H, pentyl-2), 1.27 (s, 3H, H-9), 1.30 (s, 3H, 
H-10), 1.40 (m, 1H, pentyl-2), 1.89 (ddd, J = 15.8 Hz, J = 8.6 Hz, J = 6.0 Hz, 1H, pentyl-
1), 2.28 (ddd, J = 15.8 Hz, J = 8.6 Hz, J = 6.1 Hz, 1H, pentyl-1), 1.97 (m, 1H, H-5 endo), 
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2.08 (m, 1H, H-6 exo), 2.18 (m, 1H, H-5 exo), 2.61 (d, J = 5.9 Hz, 1H, H-4), 2.64 (m, 1H, 
H-6 endo), 3.09 (d, J = 14.2 Hz, 1H, H-8 anti), 3.47 (d, J = 14.2 Hz, 1H, H-8 syn), 6.60 (s, 
1H, =CH), 7.34 (m, 5H, Ph), 12.76 (s, 1H, NH). 13C NMR spectrum (125 MHz) in CDCl3, 
δ (ppm): 14.1 (CH3, pentyl-5), 21.9 (CH3, C-9), 22.3 (CH2, pentyl-4), 25.4 (CH2, C-5), 
24.8 (CH2, pentyl-2), 28.6 (CH3, C-10), 31.2 (CH2, pentyl-3), 34.8 (CH2, C-6), 41.7 (CH2, 
pentyl-1), 47.6 (Cq, C-7), 59.5 (CH2, C-8), 61.5 (Cq, C-1), 66.7 (CH, C-4), 107.5 (Cq, 
C2−C=), 126.6 (CH) and 129.4 (CH)(o- and m-Ph), 128.9 (CH, p-Ph), 131.4 (CH, =CH), 
136.9 (Cq, HC=C), 141.5 (Cq, Ph), 163.6 (Cq, C-2), 204.9 (Cq, pentyl-C=O), 209.4 (Cq, C-
3). 
(3R,4aS,7S,7aR,9bS)-5,6,7,7a-Tetrahydro-7a-hydroxy-11,11-dimethyl-1-pentyl-9-
phenyl-4H-4a,7-methanoindeno[7,1-de][1,2]oxathiepin-3,9b-imine 3-oxide (23).  
Yield 37 %. Accurate ESI-MS, m/z: Calcd for C25H31NNaO3S [M + Na]+: 448.1915. 
Found: 448.1917 (Δ [mmu] 0.2). ESI-MS: (M = 425.595) 448 [M + Na]+. Rf = 0.75 
(eluent ethyl acetate/hexane 1:1). IR spectrum (selected bands), cm−1: 3303 s ν(OH), 1653 
m ν(C=C), 1324 and 1059 s ν(SON). 1H NMR spectrum (500 MHz) in CDCl3, δ (ppm): 
0.76 (t, 7.1 Hz, 3H, pentyl-5), 0.95 (m. 2H, pentyl-3), 0.97 (s, 3H, H-9 or H-10), 1.08 (m, 
2H, pentyl-4), 1.10 (m, 2H, pentyl-2), 1.43 (s, 3H, H-10 or H-9), 1.50 (m, 1H, H-5 endo), 
1.72 (m, 1H, H-6 exo), 1.75 (m, 2H, pentyl-1), 1.78 (m, 1H, H-5 exo), 1.90 (m, 1H, H-6 
endo), 2.11 (d, J = 5.8 Hz, 1H, H-4), 2.76 (s, 1H, OH), 3.07 (d, J = 14.0Hz, 1H, H-8 anti or 
syn), 3.43 (d, J = 14.0 Hz, 1H, H-8 syn or anti), 5.80 (s, 1H, =CH), 7.23 (m, 2H, o-Ph), 
7.34 (m, 3H, m- and p-Ph). 13C NMR spectrum (125 MHz) in CDCl3, δ (ppm): 14.1 (CH3, 
pentyl-5), 22.4 (CH2, pentyl-4), 22.5 (CH3, C-9 or C-10), 23.2 (CH3, C-10 or C-9), 24.8 
(CH2, C-5), 26.7 (CH2, pentyl-2), 27.7 (CH2, C-6), 31.3 (CH2, pentyl-3), 30.2 (CH2, 
pentyl-1), 51.2 (Cq, C-7), 52.3 (CH2, C-8), 53.2 (CH, C-4), 60.6 (Cq, C-1), 84.0 (Cq,C-2), 
90.0 (Cq, C-3), 125.5 (Cq, C2-C=), 128.2 (2 CH, o- and p-Ph), 128.5 (CH, m-Ph), 136.0 
(Cq, CH=C), 138.5 (CH, =CH), 140.1 (Cq, Ph), 151.4 (Cq, =C-O). 
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 1H and 13C NMR spectra of compounds  
 12a, 12b, 13a, 17a, 17b, 18, 19, 20, 21a, 21b, 22a, 22b and 23 
1H NMR spectrum (500 MHz) of compound 12a 
 
13C NMR spectrum (125 MHz) of compound 12a 
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1H NMR spectrum (500 MHz) of compound 13a 
 
13C NMR spectrum (125 MHz) of compound 13a 
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1H NMR spectrum (500 MHz) of compound 12b 
 
 
13C NMR spectrum (125 MHz) of compound 12b 
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1H NMR spectrum (500 MHz) of compound 17a 
 
 
13C NMR spectrum (125 MHz) of compound 17a 
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1H NMR spectrum (500 MHz) of compound 17b  
 
 
13C NMR spectrum (125 MHz) of compound 17b 
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1H NMR spectrum (500 MHz) of compound 18 
 
 
1H NMR spectrum (500 MHz) of compound 19 
 
13C NMR spectrum (125 MHz) of compound 19 
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1H NMR spectrum (500 MHz) of compound 20  
 
 
13C NMR spectrum (125 MHz) of compound 20 
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1H NMR spectrum (500 MHz) of compound 21a  
 
 
13C NMR spectrum (125 MHz) of compound 21a 
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1H NMR spectrum (500 MHz) of compound 21b 
 
 
13C NMR spectrum (125 MHz) of compound 21b 
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1H NMR spectrum (500 MHz) of compound 22a 
 
 
13C NMR spectrum (125 MHz) of compound 22a 
 
 
 
 
 51 
1H NMR spectrum (500 MHz) of the crude reaction product 21b  22b + 23  
 
 
13C NMR spectrum (125 MHz) of the crude reaction product 21b  22b + 23 
 
 
 
 
 52 
1H NMR spectrum (500 MHz) of compound 22b  
 
 
13C NMR spectrum (125 MHz) of compound 22b 
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1H NMR spectrum (500 MHz) of compound 23 
 
 
13C NMR spectrum (125 MHz) of compound 23 
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